Evidence map›Paper›PMID 26796539›Full record

ArticleScientific reports2016

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.

Caroline Galeotti, Pushpa Hegde, Mrinmoy Das, Emmanuel Stephen-Victor, Fernando Canale, Marcos Muñoz, Varun K Sharma, Jordan D Dimitrov, Srini V Kaveri, Jagadeesh Bayry

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intravenous Immunoglobulin Therapy EliminatesInternational journal of molecular sciences · 2019
    Article
  5. A review on heme oxygenase-1 induction: is it a necessary evil.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Caroline GaleottiInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Pushpa HegdeInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Mrinmoy DasInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Emmanuel Stephen-VictorInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Fernando CanaleInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Marcos MuñozInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Varun K SharmaInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Jordan D DimitrovInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Srini V KaveriInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Jagadeesh BayryInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, F-75006, France.
Inserm · FRCentre de Recherche des Cordeliers · FRDélégation Paris 5 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravenous immunoglobulin G (IVIG) is used in the therapy of various autoimmune and inflammatory conditions. The mechanisms by which IVIG exerts anti-inflammatory effects are not completely understood. IVIG interacts with numerous components of the immune system including dendritic cells, macrophages, T and B cells and modulate their functions. Recent studies have reported that heme oxygenase-1 (HO-1) pathway plays an important role in the regulation of inflammatory response in several pathologies. Several therapeutic agents exert anti-inflammatory effects via induction of HO-1. Therefore, we aimed at exploring if anti-inflammatory effects of IVIG are mediated via HO-1 pathway. Confirming the previous reports, we report that IVIG exerts anti-inflammatory effects on innate cells as shown by the inhibitory effects on IL-6 and nitric oxide production and confers protection in experimental autoimmune encephalomyelitis (EAE) model. However, these effects were not associated with an induction of HO-1 either in innate cells such as monocytes, dendritic cells and macrophages or in the kidneys and liver of IVIG-treated EAE mice. Also, inhibition of endogenous HO-1 did not modify anti-inflammatory effects of IVIG. These results thus indicate that IVIG exerts anti-inflammatory effects independent of HO-1 pathway.

Indexed as

AnimalsAnti-Inflammatory AgentsCytoprotectionDendritic CellsEncephalomyelitis, Autoimmune, ExperimentalEnzyme InductionHeme Oxygenase-1HumansImmunoglobulins, IntravenousMacrophagesMiceMice, Inbred C57BLMonocytesProtective AgentsRAW 264.7 CellsAnti-Inflammatory AgentsHeme Oxygenase-1Immunoglobulins, IntravenousProtective Agents

Identifiers

PMID26796539
PMCPMC4726216
OpenAlexW2278862336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.